MétaCan
Menu
Back to cohort
Record W4401158013 · doi:10.1093/brain/awae142

Parkinson’s disease variant detection and disclosure: PD GENEration, a North American study

2024· article· en· W4401158013 on OpenAlexfundaboutno aff
Lola Cook, Jennifer Verbrugge, Tae‐Hwi Schwantes‐An, Jeanine Schulze, Tatiana Foroud, Anne Hall, Karen Marder, Ignácio F. Mata, Niccolò E. Mencacci, Martha Nance, Michael A. Schwarzschild, Tanya Simuni, Susan Bressman, Anne‐Marie Wills, Hubert H. Fernandez, Irene Litvan, Kelly E. Lyons, Holly A. Shill, Carlos Singer, Thomas F. Tropea, Nora Vanegas Arroyave, Janfreisy Carbonell, Rossy Cruz Vicioso, Linn Katus, Joseph F. Quinn, Priscila D. Hodges, Yan Meng, Samuel P. Strom, Cornelis Blauwendraat, Katja Lohmann, Cynthia Casaceli, Shilpa C. Rao, Kamalini Ghosh Galvelis, Anna Naito, James C. Beck, Roy N. Alcalay

Bibliographic record

VenueBrain · 2024
Typearticle
Languageen
FieldMedicine
TopicParkinson's Disease Mechanisms and Treatments
Canadian institutionsnot available
FundersNational Institute of Neurological Disorders and StrokeNational Institute on AgingSchool of Medicine, Indiana UniversityParkinsonfondenGenentechNational Institutes of HealthCurePSPServierCleveland Clinic FoundationFarmer Family FoundationBiogenNorthwestern UniversityAmneal PharmaceuticalsSutter HealthParkinson Study GroupSunovionLewy Body Dementia AssociationBarrow Neurological FoundationUniversity of TorontoCleveland ClinicParkinson's FoundationTeva Pharmaceutical IndustriesJazz PharmaceuticalsCHDI FoundationEli Lilly and CompanyU.S. Department of DefenseSanofiUCB PharmaRevanceMichael J. Fox Foundation for Parkinson's Research
KeywordsLRRK2Genetic testingDiseaseMedicineMedical geneticsPopulationPrecision medicineGenetic counselingClinical trialPersonalized medicineParkinson's diseaseFamily medicineGerontologyGeneticsInternal medicineGeneBiologyPathologyEnvironmental health

Abstract

fetched live from OpenAlex

Variants in seven genes (LRRK2, GBA1, PRKN, SNCA, PINK1, PARK7 and VPS35) have been formally adjudicated as causal contributors to Parkinson's disease; however, individuals with Parkinson's disease are often unaware of their genetic status since clinical testing is infrequently offered. As a result, genetic information is not incorporated into clinical care, and variant-targeted precision medicine trials struggle to enrol people with Parkinson's disease. Understanding the yield of genetic testing using an established gene panel in a large, geographically diverse North American population would help patients, clinicians, clinical researchers, laboratories and insurers better understand the importance of genetics in approaching Parkinson's disease. PD GENEration is an ongoing multi-centre, observational study (NCT04057794, NCT04994015) offering genetic testing with results disclosure and genetic counselling to those in the US (including Puerto Rico), Canada and the Dominican Republic, through local clinical sites or remotely through self-enrolment. DNA samples are analysed by next-generation sequencing including deletion/duplication analysis (Fulgent Genetics) with targeted testing of seven major Parkinson's disease-related genes. Variants classified as pathogenic/likely pathogenic/risk variants are disclosed to all tested participants by either neurologists or genetic counsellors. Demographic and clinical features are collected at baseline visits. Between September 2019 and June 2023, the study enrolled 10 510 participants across >85 centres, with 8301 having received results. Participants were: 59% male; 86% White, 2% Asian, 4% Black/African American, 9% Hispanic/Latino; mean age 67.4 ± 10.8 years. Reportable genetic variants were observed in 13% of all participants, including 18% of participants with one or more 'high risk factors' for a genetic aetiology: early onset (<50 years), high-risk ancestry (Ashkenazi Jewish/Basque/North African Berber), an affected first-degree relative; and, importantly, in 9.1% of people with none of these risk factors. Reportable variants in GBA1 were identified in 7.7% of all participants; 2.4% in LRRK2; 2.1% in PRKN; 0.1% in SNCA; and 0.2% in PINK1, PARK7 or VPS35 combined. Variants in more than one of the seven genes were identified in 0.4% of participants. Approximately 13% of study participants had a reportable genetic variant, with a 9% yield in people with no high-risk factors. This supports the promotion of universal access to genetic testing for Parkinson's disease, as well as therapeutic trials for GBA1 and LRRK2-related Parkinson's disease.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.399
Threshold uncertainty score0.475

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.267
Teacher spread0.251 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations89
Published2024
Admission routes2
Has abstractyes

Explore more

Same venueBrainSame topicParkinson's Disease Mechanisms and TreatmentsFrench-language works237,207